Table 2.
Recent studies of portal vein recanalization (PVR)/angioplasty in reported series.
| First author, year | n | Age, year | Cause | Technique | Follow up, month | Stent patency | Death |
|---|---|---|---|---|---|---|---|
| Semiz-Oysu et al. (106) | 19 | Mean 36.4 (0.75–79) | N/A | TH, TJ+TH, balloon + stent | 2–58 | 13 | 5 |
| Jeon et al. (108) | 21 | Mean 65.6 (26–78) | HPB surgery | TH, balloon + stent | mean 12.5 (1.4–25) |
20 | 0 |
| Kato et al. (103) | 29 | 65.9 ± 10.0 (38–83) | HPB surgery | TH, surgical approach via the ileocolic vein, balloon + stent | 19.1 ± 24.9 | 22 | 1 |
| Cavalcante et al. (107) | 22 | Median 2.7 (0.7–11.8) | Liver transplantation | transmesenteric approach via minilaparotomy with or without TH, balloon + stent | Median 88.9 (20.9–159.4) | 17 | 2 |
| Naik et al. (105) | 19 | Median12 (7–15) | Liver transplantation | TH, TS, balloon | Median 16 (5–35) |
18 | 0 |
| Marot et al. (100) | 13 | 47 ± 12 (22–60) | Unknown (3), inflammation (7), abnormal coagulation factors (5) | TH, balloon + stent | 42 ± 28 6–112) | 10 | 2 |
| Kim et al. (110) | 31 | Mean 52 (25–62) | Liver transplantation | TH, balloon + stent | Median 54.2 (0.5–192.4) | 26 | 2 |
| Mugu et al. (102) | 38 | 60.1 ± 11.3 (22.3–78.3) | HPB surgery | TH, TS, balloon + stent | 8.6 ± 8.8 | 29 | 6 |
| Lee et al. (101) | 60 | 62.5 ± 13.7 (18–88) | HPB surgery | TH, balloon + stent | 20.8 ± 24 (0–101.5) | 47 | 14 |
TH, transhepatic; TJ, transjugular; TS, transsplenic; N/A, not available; HPB, hepatobiliary or pancreatic.